Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
- Conditions
- Ovarian Cancer
- Interventions
- Biological: OC-EIEs
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03393962
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
🇨🇳Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
Engineered Immune Effectors Against Ovarian Cancer
- Conditions
- Ovarian Cancer
- Interventions
- Biological: OC-CTLs
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03362606
- Locations
- 🇨🇳
Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
🇨🇳Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
Engineered Immune Effectors Against Cervical Cancer
- Conditions
- Cervical Cancer
- Interventions
- Biological: CC-EIEs
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03362619
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
🇨🇳Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
- Conditions
- Ewing SarcomaSarcomaOsteoid Sarcoma
- Interventions
- Biological: Sarcoma-specific CAR-T cells
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03356782
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Intervention of CAR-T Against Cervical Cancer
- Conditions
- Cervical Cancer
- Interventions
- Biological: Cervical cancer-specific CAR-T cells
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03356795
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Antigen-specific T Cells Against Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Biological: Lung cancer-specific T cells
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03356808
- Locations
- 🇨🇳
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
🇨🇳Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Intervention of Engineered Immune Effector T Cells Against Lung Cancer
- Conditions
- Lung CancerNSCLC
- Interventions
- Biological: LC-CTLs
- First Posted Date
- 2017-11-27
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Registration Number
- NCT03353428
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
- Conditions
- Beta-Thalassemia
- Interventions
- Genetic: Gene-modified autologous stem cells
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03351829
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
- Conditions
- Fanconi Anemia
- Interventions
- Genetic: Gene-modified autologous stem cells
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 10
- Registration Number
- NCT03351868
- Locations
- 🇨🇳
Beijing Children's Hospital, Beijing, Beijing, China
🇨🇳Capital Institute of Pediatrics affiliated Children's hospital, Beijing, Beijing, China
🇨🇳Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV
- Conditions
- Human Papilloma Virus
- Interventions
- Biological: HPV-CTLs
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Shenzhen Geno-Immune Medical Institute
- Target Recruit Count
- 100
- Registration Number
- NCT03351855
- Locations
- 🇨🇳
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China